title: Treatment of thrombotic thrombocytopenic purpura.
authors.forename: Menno
authors.initials: M
authors.lastname: van der Straaten
authors.forename: Sophie
authors.initials: S
authors.lastname: Jamart
authors.forename: Robert
authors.initials: R
authors.lastname: Wens
authors.forename: Philippe
authors.initials: P
authors.lastname: Gottignies
authors.forename: Max
authors.initials: M
authors.lastname: Dratwa
authors.forename: Jacques
authors.initials: J
authors.lastname: Devriendt
mesh_terms: D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D008297:Male; D008666:Metalloendopeptidases / Q000378:metabolism; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human